Cargando…
Novel biomarkers for neoplastic progression from ulcerative colitis to colorectal cancer: a systems biology approach
In recent studies, the void of evaluation and in-depth understanding of unknown clinically relevant potential molecular biomarkers involved in colorectal cancer (CRC) from the inflammatory stage of ulcerative colitis (UC) to CRC metastasis, which can be suitable therapeutic targets, is deeply felt....
Autores principales: | Shahnazari, Mina, Afshar, Saeid, Emami, Mohammad Hassan, Amini, Razieh, Jalali, Akram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975073/ https://www.ncbi.nlm.nih.gov/pubmed/36854781 http://dx.doi.org/10.1038/s41598-023-29344-y |
Ejemplares similares
-
A Systems Biology Approach to Identify Novel Biomarkers in Progression from Crohn’s Disease to Colorectal Cancer
por: Shokrollah, Niloofar, et al.
Publicado: (2023) -
Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis
por: Quintanilla, Isabel, et al.
Publicado: (2022) -
A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma
por: Samadi, Pouria, et al.
Publicado: (2023) -
Pulmonary function tests in ulcerative colitis
por: Amra, Babak, et al.
Publicado: (2014) -
STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis
por: Osone, Katsuya, et al.
Publicado: (2019)